Business Description
ISIN : US9418481035
Share Class Description:
WAT: Ordinary SharesTotal Employee Number:
7,900Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.36 | |||||
Debt-to-EBITDA | 5.64 | |||||
Interest Coverage | 2.54 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.39 | |||||
Beneish M-Score | -0.95 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.5 | |||||
3-Year EBITDA Growth Rate | 0.8 | |||||
3-Year EPS without NRI Growth Rate | 3 | |||||
3-Year FCF Growth Rate | 8.4 | |||||
3-Year Book Growth Rate | 71.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 12.29 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 31.13 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.09 | |||||
9-Day RSI | 41.71 | |||||
14-Day RSI | 47.76 | |||||
3-1 Month Momentum % | 13.38 | |||||
6-1 Month Momentum % | 37.43 | |||||
12-1 Month Momentum % | 40.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.86 | |||||
Quick Ratio | 1.29 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 145.93 | |||||
Days Sales Outstanding | 95.06 | |||||
Days Payable | 57.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -4.6 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 50.89 | |||||
Operating Margin % | 8.15 | |||||
Net Margin % | 3.58 | |||||
EBITDA Margin % | 20.83 | |||||
FCF Margin % | 8.59 | |||||
OCF Margin % | 11.83 | |||||
ROE % | 2.21 | |||||
ROA % | 1.3 | |||||
ROIC % | 2.58 | |||||
3-Year ROIIC % | -3.54 | |||||
ROC (Joel Greenblatt) % | 15.26 | |||||
ROCE % | 3.18 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 101.83 | |||||
Forward PE Ratio | 24.63 | |||||
PE Ratio without NRI | 29.85 | |||||
Shiller PE Ratio | 42.14 | |||||
Price-to-Owner-Earnings | 351.68 | |||||
PEG Ratio | 5.43 | |||||
PS Ratio | 6.65 | |||||
PB Ratio | 2.64 | |||||
Price-to-Free-Cash-Flow | 69.63 | |||||
Price-to-Operating-Cash-Flow | 51.75 | |||||
EV-to-EBIT | 127.06 | |||||
EV-to-Forward-EBIT | 31.37 | |||||
EV-to-EBITDA | 46.52 | |||||
EV-to-Forward-EBITDA | 19.23 | |||||
EV-to-Revenue | 9.69 | |||||
EV-to-Forward-Revenue | 6.15 | |||||
EV-to-FCF | 112.86 | |||||
Price-to-GF-Value | 0.99 | |||||
Price-to-Projected-FCF | 2.32 | |||||
Price-to-DCF (Earnings Based) | 2.1 | |||||
Price-to-DCF (FCF Based) | 6.03 | |||||
Price-to-Median-PS-Value | 1 | |||||
Earnings Yield (Greenblatt) % | 0.79 | |||||
FCF Yield % | 0.99 | |||||
Forward Rate of Return (Yacktman) % | 2.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:WAT
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Waters Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,644.249 | ||
| EPS (TTM) ($) | 4.01 | ||
| Beta | 1.4336 | ||
| 3-Year Sharpe Ratio | 0.41 | ||
| 3-Year Sortino Ratio | 0.73 | ||
| Volatility % | 38.55 | ||
| 14-Day RSI | 47.76 | ||
| 14-Day ATR ($) | 12.110186 | ||
| 20-Day SMA ($) | 410.309 | ||
| 12-1 Month Momentum % | 40.52 | ||
| 52-Week Range ($) | 282.77 - 426.22 | ||
| Shares Outstanding (Mil) | 98.25 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Waters Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Waters Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-23 | In 165 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-09 08:30 | In 152 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-09 | In 151 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-04 08:00 | In 55 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 54 days | ||
| Waters Corporation to Present at the Wells Fargo Healthcare Conference | 2026-09-09 10:15 | 402.91 (-0.60%) | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 08:00 | 374.74 (-1.73%) | ||
| Second quarter earnings results for 2026 | 2026-08-04 | 374.74 (-1.73%) | ||
| Jefferies Global Healthcare Conference | 2026-06-03 10:30 | 371.93 (-0.15%) | ||
| General meeting for 2026 | 2026-05-21 09:00 | 341.32 (+1.81%) |
Waters Corp Frequently Asked Questions
Guru Commentaries on NYSE:WAT
Waters (WAT), a life sciences tools provider, saw its shares respond favorably to solid results in their legacy Waters business as well as in the recently acquired biosciences and diagnostics businesses from Becton Dickinson. This positive performance reflects the company's strong positioning within the growing AI data center construction boom, which is driving high revenue and backlog growth across the sector.
Waters Corporation (WAT) underperformed on the announcement that it will acquire Becton Dickinson’s Biosciences and Diagnostics divisions. While we take a skeptical view toward transformational M&A, we do see the strategic logic of the deal, and we have confidence in management’s ability to execute on commercial improvements and cost synergies. We continue to have a favorable view of WAT’s core business and the management team.
We took advantage of the market volatility following the tariff announcements to add to these positions at what we viewed as compelling valuations. Backed by our deep research, we had the conviction to invest further in these high-quality businesses, which we believe are well equipped to navigate uncertainty.